A new randomized clinical trial published in JAMA Network Open shows that a mailed fecal immunochemical test (FIT) outreach program…
Browsing: Clinical Updates
This article explores how electronic health records (EHRs), while beneficial for data access and care coordination, contribute significantly to provider…
The FDA has approved the Rectal Expulsion Device (RED), developed at the University of Michigan by Drs. Eric Shah and…
A randomized trial at a community health center showed that patient navigation significantly increased colonoscopy completion among patients with an…
Here’s a concise summary of Dr. David Johnson’s commentary on the latest US Multi-Society Task Force recommendations for colonoscopy preparation,…
Johnson & Johnson’s Tremfya (guselkumab) has been FDA-approved for Crohn’s disease, joining IL-23 class peers Skyrizi and Omvoh. Backed by…
Exact Sciences has launched Cologuard Plus™, a new FDA-approved, noninvasive colorectal cancer (CRC) screening test for average-risk adults aged 45+.…
For patients with irritable bowel syndrome with constipation (IBS-C), education is central to adherence to therapy and improved outcomes. Working…
AGA has partnered with Beyond Celiac, the leading nonprofit organization dedicated to finding a cure for celiac disease, to establish…
The FDA has approved Tremfya (guselkumab) for moderate to severe Crohn’s disease, offering a convenient at-home self-injection option in addition…